JDD July 2024 Issue Highlights
This July, the Journal of Drugs in Dermatology (JDD) is proud to present a special edition focused on "Bridging the Gap in Dermatology." Our Editor's Picks this month highlight groundbreaking research and discussions aimed at promoting inclusivity, representation, and innovation in dermatologic care. From advancements in sun protection to the role of social media in healthcare, these pieces provid …
This July, the Journal of Drugs in Dermatology (JDD) is proud to present a special edition focused on "Bridging the Gap in Dermatology." Our Editor's Picks this month highlight groundbreaking research and discussions aimed at promoting inclusivity, representation, and innovation in dermatologic care. From advancements in sun protection to the role of social media in healthcare, these pieces provid … 
Dermatologic side effects are among the most frequent unexpected side effects of cancer treatments.1,2 Targeted therapies are associated with a lower incidence of systemic adverse events, but a higher incidence of dermatological AEs - including acneiform rash and pruritus.3
Skin toxicities can have a dramatic negative impact on QOL and overall success of treatment therapies.3
Skin toxicities oft … 
Atopic dermatitis (AD) is a chronic skin condition characterized by pruritus, inflammation, and acute flare-ups of eczematous lesions over dry skin.1 The wide range of clinical manifestations, the visible nature of the disease, and the intense itching significantly affects patients’ quality of life.2 Up to 80% of children with AD experience sleep disturbances.3 Sixty-seven percent of children … 
Isotretinoin can provide a definitive cure for many patients with severe or recalcitrant acne, as well as other conditions. However, dosing and lab monitoring practices for this drug vary widely. In this installment of our Therapeutic Cheat Sheet series, we set the record straight on isotretinoin.
[caption id="attachment_8787" align="alignleft" width="1275"] Click image to enlarge or downlo … 
The second of a two-part series with clinical pearls for your dermatology practice from the 2018 Coastal Dermatology Symposium. Be sure not to miss all the useful points in Part I.
From Dr. Julie Harper’s talk “The Latest on Acne”
OCPs are still a viable treatment for female patients with acne. You should be sure to take a thorough history to elucidate any risk factors for venous t … 